Global Hereditary Angioedema Market: Industry Analysis & Outlook (2017-2021) – Upcoming Novel Drugs to Drive Growth of Hereditary Angioedema Market – Research and Markets

DUBLIN–(BUSINESS WIRE)–The „Global Hereditary Angioedema Market: Industry Analysis & Outlook (2017-2021)” report has been added to Research and Markets’ offering.

Hereditary Angioedema (HAE) is a rare hereditary disease caused by a genetic deficiency in a gene known as C1 inhibitor (C1-INH). It is characterized by attacks of edema (swelling). These are unpredictable and can affect various areas of the body including the stomach, hands, feet, arms, legs, genitals, throat, and face. Depending on the severity of the disease, some people can have many attacks each month, while others go months without an attack.

The global hereditary angioedema market is set to experience favourable growth driven by factors such as increasing diagnosis of hereditary angioedema & rising health care expenditure. Further, the scope of growth for this market will be broadened by increasing uptake of prophylaxis therapy and global economic development. The major trends that can be observed in this market include introduction of novel drugs, increasing awareness for HAE and oral medication for HAE attacks.

The report „Global Hereditary Angioedema Market: Industry Analysis & Outlook (2017-2021)” analyses the development of this market, with focus on the U.S. and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players Shire Plc., CSL Limited, Pharming Group N.V. & BioCryst Pharmaceuticals Inc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global Hereditary Angioedema market along with the study of the regional markets.

Companies Mentioned

  • BioCryst Pharmaceuticals Inc.
  • CSL Limited
  • Pharming Group N.V.
  • Shire Plc.

Key Topics Covered:

1. Overview

2. Global Hereditary Angioedema Market

3. Regional Market

4. Market Dynamics

5. Competition

6. Company Profiles

For more information about this report visit